000766.SZ Stock Analysis
00
Avoid
Based on Eyestock quantitative analysis, 000766.SZ`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly overvalued
Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company is headquartered in Tonghua, Jilin and currently employs 1,699 full-time employees. The firm's main products consist of Chinese patent drugs, chemical drugs and bulk drugs, among others. The Company’s products are used in anti-tumor, microbial, digestive system, skeletal and muscle system, gynecology, nervous system and other areas. The firm distributes its products mainly in domestic market.